论文信息 - T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028. - 字舞流文

T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028.

J. Lunceford | M. Ayers | H. Rugo | Y. Bang | Ping Yang | K. Emancipator | J. Soria | R. Cristescu | A. Joe | P. Ott | Juanita Lopez | S. Piha-Paul | R. Cohen | B. O'Neil | T. Doi | J. Mehnert | E. V. van Brummelen | J. Bennouna | K. Stein | A. Razak | E. van Brummelen